Tags Topics Support CSPI today As a nonprofit organization that takes no donations from industry or government, CSPI relies on the support of donors to continue our work in securing a safe, nutritious, and transparent food system
A medication that appears stronger in one headline may not be the best option for a specific patient
It remains an experimental compound, and its full safety profile is still being established through ongoing Phase 2 and Phase 3 trials
Adding this to your routine helps stabilize insulin sensitivity and offers a protective buffer against the digestive sluggishness that often catches GLP-1 users off guard
Compounded semaglutide, available through licensed pharmacies under drug shortage provisions, is the only lower-cost alternative currently available
That's in contrast to single -agonist medications like Novo Nordisks Wegovy and Ozempic, which stimulate the bodys GLP-1 receptors to slow digestion, causing people to feel fuller longer after eating